![Cancers | Free Full-Text | Prolonged Exposure to Oxaliplatin during HIPEC Improves Effectiveness in a Preclinical Micrometastasis Model Cancers | Free Full-Text | Prolonged Exposure to Oxaliplatin during HIPEC Improves Effectiveness in a Preclinical Micrometastasis Model](https://www.mdpi.com/cancers/cancers-14-01158/article_deploy/html/images/cancers-14-01158-g002.png)
Cancers | Free Full-Text | Prolonged Exposure to Oxaliplatin during HIPEC Improves Effectiveness in a Preclinical Micrometastasis Model
![Cancers | Free Full-Text | Prolonged Exposure to Oxaliplatin during HIPEC Improves Effectiveness in a Preclinical Micrometastasis Model Cancers | Free Full-Text | Prolonged Exposure to Oxaliplatin during HIPEC Improves Effectiveness in a Preclinical Micrometastasis Model](https://www.mdpi.com/cancers/cancers-14-01158/article_deploy/html/images/cancers-14-01158-g006-550.jpg)
Cancers | Free Full-Text | Prolonged Exposure to Oxaliplatin during HIPEC Improves Effectiveness in a Preclinical Micrometastasis Model
![Cancers | Free Full-Text | Prolonged Exposure to Oxaliplatin during HIPEC Improves Effectiveness in a Preclinical Micrometastasis Model Cancers | Free Full-Text | Prolonged Exposure to Oxaliplatin during HIPEC Improves Effectiveness in a Preclinical Micrometastasis Model](https://www.mdpi.com/cancers/cancers-14-01158/article_deploy/html/images/cancers-14-01158-g004.png)
Cancers | Free Full-Text | Prolonged Exposure to Oxaliplatin during HIPEC Improves Effectiveness in a Preclinical Micrometastasis Model
![Cancers | Free Full-Text | Prolonged Exposure to Oxaliplatin during HIPEC Improves Effectiveness in a Preclinical Micrometastasis Model Cancers | Free Full-Text | Prolonged Exposure to Oxaliplatin during HIPEC Improves Effectiveness in a Preclinical Micrometastasis Model](https://www.mdpi.com/cancers/cancers-14-01158/article_deploy/html/images/cancers-14-01158-g003-550.jpg)